Global Health Limited , a leading multi-specialty tertiary care provider in North and East India, has reported robust financial results for the second quarter of fiscal year 2026, while also expanding its hospital network.

Q2 FY26 Financial Highlights

Global Health delivered strong performance in Q2 FY26, with consolidated total income reaching ₹11,189.00 million, marking a 14.8% year-on-year growth. The company's profit after tax (PAT) increased by 21.1% to ₹1,584.00 million, with PAT margins improving to 14.2% from 13.4% in the same quarter last year.

Key financial metrics for Q2 FY26:

The company's Average Revenue Per Occupied Bed (ARPOB) grew by 5.5% year-on-year to ₹65,570.00, driven by an increase in realization and changes in specialty mix.

Operational Performance

Global Health witnessed strong volume growth across its network. In-patient count increased by 12.7%, while out-patient count rose by 14.9% compared to the same period last year. Occupied bed days increased by 7.7% year-on-year, representing an occupancy rate of approximately 64% on increased bed capacity.

Expansion and New Facilities

A significant milestone for Global Health was the launch of its sixth hospital, a 550-bed facility in Noida, which commenced operations in September 2025. The Noida hospital is currently operational with 226 beds, including 81 ICU beds and 5 operating theatres. Over 150 doctors across key specialties have already joined the new facility.

Mr. Pankaj Sahni, Group CEO and Director, commented on the expansion, stating, "We are extremely pleased to share that in September 2025, we launched our sixth hospital, a state-of-the-art, 550-bed facility in Noida. We are encouraged by the initial response from the community and are progressively ramping up operations."

Mumbai Project Update

Global Health has announced plans to increase the capacity of its upcoming Mumbai hospital from 500 to 750 beds. This expansion follows the receipt of additional Floor Space Index (FSI) approval from the Mumbai Housing and Area Development Authority (MHADA). The total project cost for the Mumbai facility, including land acquisition and FSI purchase, is now estimated at ₹15,300.00 million.

Other Developments

• The company added 37 new beds at its Patna facility during the quarter, bringing the total addition to 57 beds in H1 FY26 in Patna.
• Global Health received in-principle approval for allotment of 3.5 acres of land in Guwahati, Assam, with physical possession obtained after the quarter's end.
• The company initiated a year-long Cancer Awareness Program, with the inaugural campaign focusing on breast cancer awareness.

Global Health's expansion strategy and strong financial performance demonstrate its commitment to growth and improving healthcare accessibility across North and East India. The company's focus on high-end specialties and regional hubs positions it well for continued success in the healthcare sector.

About Global Health Limited

Global Health Limited operates a network of six hospitals under the "Medanta" brand across Gurugram, Indore, Ranchi, Lucknow, Patna, and Noida. With a total of 3,435 installed beds as of September 30, 2025, the company provides healthcare services in over 30 medical specialties and engages over 2,000 doctors led by experienced department heads.

Global Health Limited , operating under the brand name Medanta, has initiated the construction of a new 400-bed super-specialty hospital in Guwahati, marking a significant expansion of healthcare services in Northeast India. The groundbreaking ceremony, known as 'Bhoomi Poojan', was attended by Assam Chief Minister Dr. Himanta Biswa Sarma and Dr. Naresh Trehan, Chairman & Managing Director of Medanta.

Project Details

The new facility, set to be built at an approximate cost of Rs 500.00 crore, will be located at Industrial Estate, Sarusajai, Guwahati, along National Highway 27. This strategic location is expected to serve as a healthcare hub for the entire Northeastern region.

Comprehensive Healthcare Services

The hospital aims to offer a wide range of tertiary and quaternary care services, including:

• Transplant programs (Kidney, Liver, Lung, Heart, Bone Marrow, and Robotic)
• Cardiology and Cardiac Surgery
• Neurology and Neurosurgery
• Oncology (Medical, Surgical, and Radiation)
• Orthopedics
• Gastroenterology and GI Surgery
• Nephrology and Urology
• Respiratory Medicine
• Critical Care and Emergency Services

Economic Impact

The project is expected to generate significant employment opportunities:

These jobs will span across healthcare, administration, and support services sectors.

Medanta's Expansion Strategy

This new hospital is part of Medanta's broader expansion plan. Currently, the company operates six hospitals with a total of 3,362 installed beds. Four additional hospitals, including the Guwahati facility, are in various stages of planning or construction, which will add approximately 2,000 more beds to their capacity.

Addressing Healthcare Gaps

Dr. Naresh Trehan emphasized the importance of this project, stating, "North East India is a region that has long been underserved with respect to heath care services. At Medanta, we believe that quality healthcare should be a right, not a privilege."

Mr. Pankaj Sahni, Group CEO of Medanta, added, "Our upcoming 400+ bed super-specialty hospital in Guwahati will allow us to bridge the healthcare gap to underserved areas in the Northeast and bring world-class, high-end medical care within easy reach of over 50 million people."

This development represents a significant step towards improving healthcare accessibility and quality in Northeast India, potentially transforming the region's medical landscape.